{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T23:19:39Z","timestamp":1777763979094,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA211723"],"award-info":[{"award-number":["R01CA211723"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["K07CA216326"],"award-info":[{"award-number":["K07CA216326"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["IHS-2017C3-9211"],"award-info":[{"award-number":["IHS-2017C3-9211"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100029613","name":"American Association of Obstetricians and Gynecologists Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100029613","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["IHS-2017C3-9211"],"award-info":[{"award-number":["IHS-2017C3-9211"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013575","name":"A Blade of Grass","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013575","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ygyno.2025.07.007","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T20:28:15Z","timestamp":1755808095000},"page":"169-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Virtual versus reality: Assessing the accuracy of a digital cancer risk assessment tool in a gynecologic oncology clinic"],"prefix":"10.1016","volume":"200","author":[{"given":"Sara","family":"Perelmuter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda C.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Danyal","family":"Ahsan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily M.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Primiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamar Nicole","family":"Soussana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle R.","family":"Chandler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi N.","family":"Sharaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa K.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.ygyno.2025.07.007_bb0005","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1200\/JCO.19.02010","article-title":"Cascading after Peridiagnostic Cancer genetic testing: an alternative to population-based screening","volume":"38","author":"Offit","year":"2020","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"34","key":"10.1016\/j.ygyno.2025.07.007_bb0010","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1200\/JCO.2017.73.6314","article-title":"National Estimates of genetic testing in women with a history of breast or ovarian Cancer","volume":"35","author":"Childers","year":"2017","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"16","key":"10.1016\/j.ygyno.2025.07.007_bb0015","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa022152","article-title":"Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer","volume":"347","author":"Fisher","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.ygyno.2025.07.007_bb0020","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of Risk-Reducing Surgery in BRCA1 or BRCA2 mutation carriers with Cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"issue":"18","key":"10.1016\/j.ygyno.2025.07.007_bb0025","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and bowel project P-1 study","volume":"90","author":"Fisher","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.ygyno.2025.07.007_bb0030","first-page":"715","article-title":"History, genetics, and strategies for Cancer prevention in lynch syndrome","volume":"12","author":"Kastrinos","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"10.1016\/j.ygyno.2025.07.007_bb0035","author":"Cancer Genetics Risk Assessment and Counseling (PDQ\u00ae) - NCI"},{"issue":"6","key":"10.1016\/j.ygyno.2025.07.007_bb0040","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1097\/AOG.0000000000003562","article-title":"ACOG COMMITTEE OPINION, Number 793","volume":"134","author":"Hereditary Cancer Syndromes and Risk Assessment","year":"2019","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.07.007_bb0045","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.56078","article-title":"Cost-effectiveness of population-based multigene testing for breast and ovarian cancer prevention","volume":"7","author":"Guo","year":"2024","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.ygyno.2025.07.007_bb0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/13696998.2022.2152233","article-title":"A review of the cost-effectiveness of genetic testing for germline variants in familial cancer","volume":"26","author":"Teppala","year":"2023","journal-title":"J. Med. Econ."},{"key":"10.1016\/j.ygyno.2025.07.007_bb0055","doi-asserted-by":"crossref","unstructured":"NCCN guidelines version 2.2021. J Natl Compr Canc Netw. 2021 Jan 6;19(1):77-102. doi:10.6004\/jnccn.2021.0001.","DOI":"10.6004\/jnccn.2021.0001"},{"issue":"10","key":"10.1016\/j.ygyno.2025.07.007_bb0060","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.6004\/jnccn.2020.0048","article-title":"NCCN guidelines insights: colorectal Cancer screening, version 2.2020","volume":"18","author":"Provenzale","year":"2020","journal-title":"J. Natl. Compr. Cancer Netw. JNCCN"},{"issue":"7","key":"10.1016\/j.ygyno.2025.07.007_bb0065","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/sim.1668","article-title":"A breast cancer prediction model incorporating familial and personal risk factors","volume":"23","author":"Tyrer","year":"2004","journal-title":"Stat. Med."},{"issue":"2","key":"10.1016\/j.ygyno.2025.07.007_bb0070","first-page":"75","article-title":"American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J. Clin."},{"issue":"22","key":"10.1016\/j.ygyno.2025.07.007_bb0075","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1200\/JCO.2010.28.0784","article-title":"Evaluation of the Tyrer-Cuzick (international breast cancer intervention study) model for breast cancer risk prediction in women with atypical hyperplasia","volume":"28","author":"Boughey","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2025.07.007_bb0080","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1186\/s13058-014-0451-5","article-title":"Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: findings from the placebo arm of the international breast cancer intervention study I","volume":"16","author":"Warwick","year":"2014","journal-title":"Breast Cancer Res. BCR"},{"issue":"1","key":"10.1016\/j.ygyno.2025.07.007_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s44276-024-00099-x","article-title":"Commentary: why is genetic testing underutilized worldwide? The case for hereditary breast cancer","volume":"2","author":"Pederson","year":"2024","journal-title":"BJC Rep."},{"issue":"4","key":"10.1016\/j.ygyno.2025.07.007_bb0090","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10897-016-0040-0","article-title":"Why is Cancer genetic counseling underutilized by women identified as at risk for hereditary breast cancer? Patient perceptions of barriers following a referral letter","volume":"26","author":"Kne","year":"2017","journal-title":"J. Genet. Couns."},{"key":"10.1016\/j.ygyno.2025.07.007_bb0095","author":"Family History as a Risk Assessment Tool"},{"issue":"7","key":"10.1016\/j.ygyno.2025.07.007_bb0100","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/jama.2019.10987","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA -related cancer: US preventive services task force recommendation statement","volume":"322","author":"US Preventive Services Task Force","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ygyno.2025.07.007_bb0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2014.09.009","article-title":"SGO clinical practice committee. Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions","volume":"136","author":"Lancaster","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2025.07.007_bb0110","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/fampra\/cmn053","article-title":"Interviews with primary care physicians regarding taking and interpreting the cancer family history","volume":"25","author":"Wood","year":"2008","journal-title":"Fam. Pract."},{"key":"10.1016\/j.ygyno.2025.07.007_bb0115","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1200\/CCI.21.00004","article-title":"Leveraging health information technology to collect family cancer history: a systematic review and Meta-analysis","volume":"5","author":"Li","year":"2021","journal-title":"JCO Clin. Cancer Inform."},{"issue":"1","key":"10.1016\/j.ygyno.2025.07.007_bb0120","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13053-021-00177-y","article-title":"Clinical implementation of an oncology-specific family health history risk assessment tool","volume":"19","author":"Fung","year":"2021","journal-title":"Hered Cancer Clin. Pract."},{"key":"10.1016\/j.ygyno.2025.07.007_bb0125","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ygyno.2023.04.001","article-title":"Web-based tool for cancer family history collection: a prospective randomized controlled trial","volume":"173","author":"Frey","year":"2023","journal-title":"Gynecol. Oncol."},{"issue":"25","key":"10.1016\/j.ygyno.2025.07.007_bb0130","article-title":"Digital tool for genetic cancer risk assessment in a historically underserved population: a randomized controlled trial","volume":"S0002-9378","author":"Webster","year":"2025","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2025.07.007_bb0135","doi-asserted-by":"crossref","unstructured":"NCCN guidelines Version 2.2020. J Natl Compr Canc Netw. 2020 Oct 1;18(10):1312-1320. doi:10.6004\/jnccn.2020.0048.","DOI":"10.6004\/jnccn.2020.0048"},{"issue":"2","key":"10.1016\/j.ygyno.2025.07.007_bb0140","first-page":"47","article-title":"Performance of the Tyrer-Cuzick 8 breast cancer risk model across races: a review","volume":"4","author":"Porterhouse","year":"2022","journal-title":"J. Cancer Immunol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.07.007_bb0145","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inform."},{"issue":"8","key":"10.1016\/j.ygyno.2025.07.007_bb0150","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1200\/JCO.2013.50.9257","article-title":"American Society of Clinical Oncology expert statement: collection and use of a cancer family history for oncology providers","volume":"32","author":"Lu","year":"2014","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2025.07.007_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ygyno.2024.02.028","article-title":"Integration and usability of a digital cancer risk stratification tool to optimize identification of patients at risk for hereditary cancers: a pilot study","volume":"183","author":"Webster","year":"2024","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2025.07.007_bb0160","first-page":"239","article-title":"Cancer risk assessment: quality and impact of the family history interview","volume":"27","author":"Murff","year":"2004","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.ygyno.2025.07.007_bb0165","article-title":"Room for improvement in capturing cancer family history in a gynecologic oncology outpatient setting","volume":"40","author":"Lin","year":"2022","journal-title":"Gynecol. Oncol. Rep."},{"key":"10.1016\/j.ygyno.2025.07.007_bb0170","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13053-018-0099-8","article-title":"Validation of a digital identification tool for individuals at risk for hereditary cancer syndromes","volume":"17","author":"Bucheit","year":"2019","journal-title":"Hered Cancer Clin. Pract."},{"key":"10.1016\/j.ygyno.2025.07.007_bb0175","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S2352-5789(23)00231-X","article-title":"10 validation of a hereditary cancer risk assessment scoring tool for use by non-genetics trained healthcare workers","volume":"48","author":"Zielenbach","year":"2023","journal-title":"Gynecol. Oncol. Rep."},{"issue":"2","key":"10.1016\/j.ygyno.2025.07.007_bb0180","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/13814788.2013.840825","article-title":"Family history tools for primary care are not ready yet to be implemented. A systematic review","volume":"20","author":"De Hoog","year":"2014","journal-title":"Eur. J. Gen. Pract."},{"key":"10.1016\/j.ygyno.2025.07.007_bb0185","article-title":"Chatbot artificial intelligence for genetic Cancer risk assessment and counseling: a systematic review and Meta-analysis","volume":"7","author":"Webster","year":"2023","journal-title":"JCO Clin. Cancer Inform."},{"issue":"10","key":"10.1016\/j.ygyno.2025.07.007_bb0190","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.34574","article-title":"Association of disparities in family history and family Cancer history in the electronic health record with sex, race, Hispanic or Latino ethnicity, and language preference in 2 large US health care systems","volume":"5","author":"Chavez-Yenter","year":"2022","journal-title":"JAMA Netw. Open"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825009175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825009175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:58:22Z","timestamp":1777474702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825825009175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":38,"alternative-id":["S0090825825009175"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.07.007","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Virtual versus reality: Assessing the accuracy of a digital cancer risk assessment tool in a gynecologic oncology clinic","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}